Publication | Closed Access

The combined use of aspirin, a statin, and blood pressure–lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease

ThrombosisHypertensionBlood Pressure–lowering AgentsHealth PolicyCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular PharmacologyVascular BiologyPolypill ComponentsPublic HealthPharmacologyCoronary Artery DiseaseAnesthesiology